The Highlights:

• The International Stem Cell Meeting: Stem Cells and their Regulatory Microenvironment .
  Together with the Weizmann Institute we will revisit the whole area of stem cell research including review of the basics, analysis of the IP / patent policy, trends in the industrialization process and convergence with medical device approaches.
   
• Innovations Bio-Pharma and Medical Device: Preliminary agenda will be published shortly
   
• BioBusiness: From a scientific discovery to a profitable industryopportunities and hurdles. A series of panel discussions will address the crossroad and meeting site between tech-transfer, regulation, investment at various stages and marketing strategies.